Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer

被引：0

作者：

Ardavanis, A

Scorilas, A

Amanatidou, A

Gerakini, F

Missitzis, I

Garoufali, A

Pissakas, G

Pateras, C

Apostolikas, N

Rigatos, G

Yiotis, I

机构：

[1] ST SAVVAS CANC HOSP,HORMONAL RECEPTORS LAB,ATHENS 11522,GREECE

[2] ST SAVVAS CANC HOSP,BREAST CLIN,ATHENS 11522,GREECE

[3] ST SAVVAS CANC HOSP,RADIOTHERAPY DEPT 2,ATHENS 11522,GREECE

[4] ST SAVVAS CANC HOSP,PATHOL LAB,ATHENS 11522,GREECE

来源：

ANTICANCER RESEARCH | 1997年 / 17卷 / 2B期

关键词：

breast cancer; prognostic factors; cathepsin D;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

One hundred and seventy three women were followed-up for a median of 62 months after surgery for Stage I-III breast cancer: The concentration of cathepsin D (CD) in tumor cytosols was compared to the standard prognostic factors for the disease and related to relapse free and overall survival and type of relapse. Three groups were identified with different prognostic profile. High CD levels significantly shorten DFS ill both node-negative and node-positive patients; a correlation between high cathepsin D levels and locoregional relapse should also be noted. This marker should be included in the initial evaluation of breast cancer as an indicator of invasiveness.

引用

页码：1405 / 1409

页数：5

共 50 条

[11] Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
E-F. Solomayer
I.J. Diel
G.C. Meyberg
Ch. Gollan
S. Bode
D. Wallwiener
G. Bastert
Breast Cancer Research and Treatment, 1998, 49 : 145 - 154
[12] PROGNOSTIC VALUE OF CATHEPSIN-D EXPRESSION IN FEMALE BREAST-CANCER
AALTONEN, M
LIPPONEN, P
KOSMA, VM
AALTOMAA, S
SYRJANEN, K
ANTICANCER RESEARCH, 1995, 15 (03) : 1033 - 1037
[13] Prognostic value of cathepsin D in breast cancer: Comparison of immunohistochemical and immunoradiometric detection methods
Gohring, UJ
Scharl, A
Thelen, U
Ahr, A
Crombach, G
Titius, BR
JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (01) : 57 - 64
[14] Prognostic value of TP53 protein accumulation in human primary breast cancer: An analysis by luminometric immunoassay on 1491 tumor cytosols
Berns, EMJJ
DeWitte, HH
Klijn, JGM
Willman, K
Look, MP
MeijervanGelder, ME
Benraad, TJ
Foekens, JA
ANTICANCER RESEARCH, 1997, 17 (4B) : 3003 - 3006
[15] Cathepsin D in the Tumor Microenvironment of Breast and Ovarian Cancers
Pranjol, Zahidul I.
Whatmore, Jacqueline L.
TUMOR MICROENVIRONMENT: MOLECULAR PLAYERS, PT A, 2020, 1259 : 1 - 16
[16] Keeping data continuous when analyzing the prognostic impact of a tumor marker: an example with cathepsin D in breast cancer
Bossard, N
Descotes, F
Bremond, AG
Bobin, Y
De Saint Hilarie, P
Golfier, F
Awada, A
Mathevet, PM
Berrerd, L
Barbier, Y
Estève, J
BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 (01) : 47 - 59
[17] Keeping Data Continuous when Analyzing the Prognostic Impact of a Tumor Marker: An Example with Cathepsin D in Breast Cancer
N. Bossard
F. Descotes
A.G. Bremond
Y. Bobin
P. De Saint Hilaire
F. Golfier
A. Awada
P.M. Mathevet
L. Berrerd
Y. Barbier
J. Estève
Breast Cancer Research and Treatment, 2003, 82 : 47 - 59
[18] Comparative prognostic value of cathepsin D and urokinase plasminogen activator, detected by immunohistochemistry, in primary breast carcinoma
Gohring, UJ
Scharl, A
Thelen, U
Ahr, A
Crombach, G
ANTICANCER RESEARCH, 1996, 16 (02) : 1011 - 1018
[19] Cathepsin D versus other prognostic factors in breast cancer. Results and controversies of a multicenter study on 2575 cases
Pelizzola, D
Gion, M
Paradiso, A
Dittadi, R
Correale, M
Mione, R
Piffanelli, A
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1996, 11 (03) : 139 - 147
[20] Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value
Alhudiri, Inas
Nolan, Christopher
Ellis, Ian
Elzagheid, Adam
Green, Andrew
Chapman, Caroline
BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (01) : 143 - 153

← 1 2 3 4 5 →